These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32484850)

  • 1. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.
    O'Mahony D; Gudmundsson A; Soiza RL; Petrovic M; Cruz-Jentoft AJ; Cherubini A; Fordham R; Byrne S; Dahly D; Gallagher P; Lavan A; Curtin D; Dalton K; Cullinan S; Flanagan E; Shiely F; Samuelsson O; Sverrisdottir A; Subbarayan S; Vandaele L; Meireson E; Montero-Errasquin B; Rexach-Cano A; Correa Perez A; Lozano-Montoya I; Vélez-Díaz-Pallarés M; Cerenzia A; Corradi S; Soledad Cotorruelo Ferreiro M; Dimitri F; Marinelli P; Martelli G; Fong Soe Khioe R; Eustace J
    Age Ageing; 2020 Jul; 49(4):605-614. PubMed ID: 32484850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
    O'Mahony D
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):15-22. PubMed ID: 31790317
    [No Abstract]   [Full Text] [Related]  

  • 4. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.
    Crowley EK; Sallevelt BTGM; Huibers CJA; Murphy KD; Spruit M; Shen Z; Boland B; Spinewine A; Dalleur O; Moutzouri E; Löwe A; Feller M; Schwab N; Adam L; Wilting I; Knol W; Rodondi N; Byrne S; O'Mahony D
    BMC Health Serv Res; 2020 Mar; 20(1):220. PubMed ID: 32183810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial.
    O'Connor MN; O'Sullivan D; Gallagher PF; Eustace J; Byrne S; O'Mahony D
    J Am Geriatr Soc; 2016 Aug; 64(8):1558-66. PubMed ID: 27365262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.
    Elliott LS; Henderson JC; Neradilek MB; Moyer NA; Ashcraft KC; Thirumaran RK
    PLoS One; 2017; 12(2):e0170905. PubMed ID: 28151991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in patterns of potentially inappropriate prescribing and adverse drug reactions in hospitalized older people: Findings from the SENATOR trial.
    O'Mahony D; Cruz-Jentoft AJ; Gudmundsson A; Soiza RL; Petrovic M; Cherubini A; Byrne S; Rochon P
    J Am Geriatr Soc; 2024 Jul; ():. PubMed ID: 38979859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people: the SENATOR trial.
    Chinmayee A; Subbarayan S; Myint PK; Cherubini A; Cruz-Jentoft AJ; Petrovic M; Gudmundsson A; Byrne S; O'Mahony D; Soiza RL
    Eur Geriatr Med; 2024 Feb; 15(1):189-199. PubMed ID: 38127206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and prevention of adverse drug reactions in multi-morbid older patients.
    Jennings E; Gallagher P; O'Mahony D
    Age Ageing; 2019 Jan; 48(1):10-13. PubMed ID: 30299453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions.
    Osanlou R; Walker L; Hughes DA; Burnside G; Pirmohamed M
    BMJ Open; 2022 Jul; 12(7):e055551. PubMed ID: 35788071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Adverse Drug Reactions in Hospitalised Older Patients Using a Software-Supported Structured Pharmacist Intervention: A Cluster Randomised Controlled Trial.
    O'Sullivan D; O'Mahony D; O'Connor MN; Gallagher P; Gallagher J; Cullinan S; O'Sullivan R; Eustace J; Byrne S
    Drugs Aging; 2016 Jan; 33(1):63-73. PubMed ID: 26597401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.
    Sallevelt BTGM; Huibers CJA; Heij JMJO; Egberts TCG; van Puijenbroek EP; Shen Z; Spruit MR; Jungo KT; Rodondi N; Dalleur O; Spinewine A; Jennings E; O'Mahony D; Wilting I; Knol W
    Drugs Aging; 2022 Jan; 39(1):59-73. PubMed ID: 34877629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.
    Parameswaran Nair N; Chalmers L; Peterson GM; Bereznicki BJ; Castelino RL; Bereznicki LR
    Clin Interv Aging; 2016; 11():497-505. PubMed ID: 27194906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study.
    Doherty AS; Boland F; Moriarty F; Fahey T; Wallace E
    Br J Gen Pract; 2023 Mar; 73(728):e211-e219. PubMed ID: 36823047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.